Rodger Novak

What they invest in

Rodger Novak is a serial entrepreneur and a Venture Partner based in Switzerland. He co-founded CRISPR Therapeutics in 2013 and is the President and Chair of the Board. With a background in pharmaceuticals and biotechnology, he led the team that IPO’d the company in 2016. Rodger's investment focus areas include Hemoglobinopathies, Immuno-Oncology, In Vivo, and Regenerative Medicine. His previous investments include CRISPR Therapeutics and Xap Therapeutics. While details about his investment check size are unavailable, his partnership and collaboration styles are not explicitly described.

Who works there

3 people on file: 3 with an email address, 3 with a phone number, 3 with a professional profile. Names and details are behind a free account.

No card. Each contact is charged once and stays yours.